Startups

Bright Minds Biosciences logo

Bright Minds Biosciences

brightmindsbio.com

Bright Minds Biosciences develops selective serotonin receptor drugs for neurological and psychiatric disorders, including epilepsy and depression.

Team

Alex VasilkevichCOO and Senior Scientific Officer
David WeinerNon-Executive Director
Ian McDonaldCEO and Director
Jan Torleif PedersenCSO and Director
Jeremy FryzukDirector
Nils BottlerDirector
Ryan CheungCFO
Stephen D. CollinsChief Medical Officer
Steve J. FarrDirector

Investments

$—Unknown datePsyMed Ventures